Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Health & Wellness Personalis Inc share price jumps 50% on deals with Merck and Moderna These developments are a validation of Personalis' business strategy and its potential in the genomics and cancer treatment space Joseph MortonDecember 19, 2024
Psychedelics Pope Francis lobbied for psychedelic reformation at newly disclosed Vatican meeting He met with New Testament critic Brian Muraresku in late 2021/early 2022, but nobody heard until now Rowan DunneDecember 19, 2024
AI and Autonomy Two tech companies tackle existential quantum threat to blockchain It’s critical to start developing quantum-resistant cryptography and creating strategies to migrate keys to safer systems Joseph MortonDecember 19, 2024
Technology Video & AI specialist Maris-Tech surges on release of ‘Uranus-Drones’ system The Israeli technology company has secured a purchase order of 100 units to be shipped by year-end Rowan DunneDecember 18, 2024
High Performance Computing Does Quantum Corporation actually deserve to be up 150% today? Just because a company has quantum in the name, doesn't mean it's a quantum computing company Joseph MortonDecember 18, 2024
Gold Employees at Nevada Gold Mines sue company for unpaid wages The lawsuit also states that the employer requires workers to perform principal job duties without compensation Joseph MortonDecember 18, 2024
Cyber Security BlackBerry sells Cylance AI cybersecurity company to Arctic Wolf in $160M deal Cylance integrated its technology with BlackBerry’s existing platforms but largely continued to operate as a standalone business unit Joseph MortonDecember 17, 2024
Lithium Rio Tinto takes advantage of Argentina’s incentives program with $2.5B investment Rio Tinto has earmarked lithium as a cornerstone of its commodity portfolio Joseph MortonDecember 17, 2024
Health & Wellness GSK small-cell lung cancer drug gets nod from European Medicines Agency Chinese-based Hansoh Pharma is conducting the trial to evaluate GSK'227 in patients with locally advanced or metastatic solid tumours Joseph MortonDecember 17, 2024